Close menu


Photo credits:

Commented by Juliane Zielonka on April 15th, 2022 | 12:01 CEST

mm2 Asia, Nvidia, Bayer AG - Digital marketplaces with high scalability

  • entertainment
  • Digitization
  • nft

Shanghai is currently experiencing the totalitarian proportions of a zero-COVID strategy. Due to soaring cases, 26 million people have to go into a harsh lockdown. After more than two years of the pandemic, the images from the Chinese metropolis seem all the more disturbing. Helplessness is spreading. People are tired of the inhumane measures. Those who test positive have to spend their quarantine in specially equipped hospitals, separated from their families and other foreign positives. The dystopian experiences of the Corona Pandemic, which everyone has personally experienced in recent months, provide an unexpectedly timely stage for arguably the most spectacular re-mastering and launch on April 21 of an Asian indie film classic in the psychological thriller genre.


Commented by André Will-Laudien on April 12th, 2022 | 18:27 CEST

Ukraine: K+S, Bayer, Ximen Mining - Fertilizer shares against the food disaster!

  • PreciousMetals
  • Agriculture

Ukraine is one of the leading export nations of wheat worldwide. However, the so-called "granary of Europe" does not primarily supply European countries because the main customers are mainly in Asia and North Africa. The most important destination for Ukrainian wheat in 2020, for example, was Egypt. The largest amount is transported overland to Odessa, where it is shipped. But now Putin has started bombing the important port city. Diesel and fertilizer are becoming scarce, so it is all the more important that there are Western specialists who are trying to secure a supply of food through special deliveries in fertilizer and technology. Where are the opportunities for investors?


Commented by André Will-Laudien on April 4th, 2022 | 12:19 CEST

Bayer, Cardiol Therapeutics, Formycon, NanoRepro: Top Biotech Stocks - Delivering!

  • Biotechnology

Due to various public easing measures, the Corona pandemic is increasingly fading into the background. It has long been a hot ride for the stock market, especially for vaccine producers, but now investors are shifting their focus to other stocks in the biotech segment. After all, there are still many diseases that confront humanity with unresolved mysteries, and the field of human medical research seems endless. We focus on interesting stocks from the sector, which corrected strongly in the wake of the Ukraine downturn but are now trending north again. These trends are still in their infancy.


Commented by Fabian Lorenz on March 24th, 2022 | 10:58 CET

Nel and Bayer shares in demand - when will Barsele Minerals explode?

  • Gold
  • Hydrogen

The stock and commodity markets remain volatile. Prices are driven by the war in Ukraine and the Corona pandemic. In recent days, commodities have been on the rise again. Brent oil is trading at around USD 120 per barrel, and gold is again setting its sights on the USD 2,000 mark. But even in this difficult-to-navigate environment, equities can make gains. Bayer shares, for example, have developed positively in recent weeks. And analysts see up to 50% upside potential for the DAX company. The invasion of Russia has also accelerated the move toward renewable energies. Hydrogen plays a central role in this. Nel has been able to profit from the fantasy in recent weeks and has now also announced a new order. Gold explorer Barsele Minerals has catch-up potential. According to a study, the share already had a lot of potential at a gold price of USD 1,350.


Commented by Nico Popp on March 22nd, 2022 | 11:22 CET

In the right place at the right time: BioNTech, Defence Therapeutics, Bayer

  • Biotechnology

For years, the pandemic has kept the world on tenterhooks. Currently, the epidemic is taking a break, at least in the media. But while the world is looking tautly at Ukraine and more and more refugees are arriving in Germany, the Omicron figures are rising once more. In some cases, the incidence in Germany is over 3,000. Although fewer and fewer people are dying, more people than ever are in quarantine. We look at BioNTech, a typical pandemic stock, and present other exciting investments from the healthcare sector.


Commented by Carsten Mainitz on March 16th, 2022 | 11:18 CET

Valneva, Perimeter Medical Imaging AI, Bayer - Immune to the crisis?

  • medtech

No sooner did the Corona pandemic seem to be under control than the world was shocked by the invasion of Russian troops in Ukraine. So far, the stock markets have digested the whole situation well. But even without further escalation, the supply situation for raw materials, among other things, will become more complex. The first signs are already awaiting us at the gas pumps. The rise in inflation will continue. Where should one invest given this mixed situation? Regardless of the economic and security situation, stocks from the healthcare sector are a good choice. Beyond fighting viruses or infectious diseases, there are great growth areas. Cancer is one such area. In addition, medical technology is increasingly bringing innovative technologies to the market, in some cases in conjunction with artificial intelligence, with disruption potential.


Commented by Juliane Zielonka on March 15th, 2022 | 13:19 CET

BASF, Almonty Industries, Bayer - These stocks are providing the momentum

  • Tungsten

New battery technology from BASF promises faster charging times. The Ludwigshafen-based conglomerate talks of 15 minutes for charging an e-car with a 600km range. New batteries require the appropriate materials, such as the element tungsten. In this area, Almonty Industries provides supplies thanks to its resource-rich mine in South Korea. Meanwhile, Bayer AG in Leverkusen is busy shrinking itself back to health. Bayer's stock has been rising somewhat since it was announced that it was divesting its pest control division.


Commented by Carsten Mainitz on March 11th, 2022 | 11:35 CET

Saturn Oil + Gas, BYD, Bayer - Winning with strong companies

  • Oil
  • Electromobility

When oil futures were trading in negative territory even for a short time at the outbreak of the Corona pandemic in the spring of 2020, many experts assumed that the black gold would remain at a low level in the long term. Only JPMorgan spoke at that time of a possible supercycle and prices over USD 100 per barrel. The analysts cited the supply shortage due to the swing towards green energy production as the reason. Due to the Ukraine crisis, supply has once again been drastically reduced, which is likely to fuel oil prices in the long term.


Commented by Stefan Feulner on March 4th, 2022 | 13:33 CET

Bayer, Defence Therapeutics, Merck KGaA - At the start of the trend

  • Biotechnology

The biotech industry is the innovative engine for a pharmaceutical industry dependent on new concepts due to the shift from blockbuster products to personalized medicine. Even before Corona, more than EUR seven billion per year was invested in R&D in 2019. The development of new drugs is particularly important for the pharmaceutical industry, as patent protection for many blockbuster drugs is expiring or has already expired. For this reason, the pharmaceutical industry is now much more often entering biotech companies in the early development phases of a new drug. The example of vaccine manufacturers has successfully highlighted this strategy, which will also be applied to other diseases in the future.


Commented by Stefan Feulner on March 2nd, 2022 | 11:31 CET

Bayer, Desert Gold, K+S - Market facing redistribution

  • Gold

Since Russia invaded Ukraine last week, the world has literally been turned upside down. There is bewilderment at the violence of the Russian president. Western nations are responding with sanctions against Russia, such as excluding Russian banks from the SWIFT system. In addition, the plan is to extend sanctions to other companies in various industries. Companies that are not affected benefit from this and gain market share. For example, the fertilizer industry is facing a redistribution of market conditions in favor of German suppliers.